CIK 0001625297 · Large accelerated filer
Supernus, Inc.
Sign in to watch- Tickers
- INDV SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412520873
- Phone
- 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Securities
- INDV Common stock Nasdaq
- SUPN Common Stock Nasdaq
- Open-market buys, last 90 days
- $53,535
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$53,535. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +45,970 | 45,970 | ||
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +63,133 | 63,133 | ||
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +63,133 | 63,133 | ||
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +78,917 | 78,917 | ||
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +47,350 | 47,350 | ||
| 2026-11-02 | Khattar Jack A. Chief Executive Officer | Other acquisition · Restricted Stock Units | +63,133 | 63,133 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition | +21,529 | 21,529 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +23,101 | 23,101 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +38,502 | 38,502 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +38,502 | 38,502 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +30,802 | 30,802 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +38,502 | 38,502 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +30,802 | 30,802 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Employee Stock Option (right to buy) | +20,791 | 20,791 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,925 | 1,925 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +3,850 | 3,850 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +5,197 | 5,197 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +4,620 | 4,620 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +107,807 | 107,807 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +2,695 | 2,695 |
Page 7 of 11 · 205 trades